Palliative vs. Disease-Modifying: Understanding the Shift in the...

a adăugat un sunet Health

2026-01-14 10:03:41 -

Palliative vs. Disease-Modifying: Understanding the Shift in the Neurodegenerative Disease Market Segment Strategy

The pharmaceutical industry is currently navigating a major strategic pivot. For nearly thirty years, the "gold standard" for Alzheimer’s was symptomatic treatment—drugs that improved memory for a few months but didn't stop the brain from shrinking. In 2026, the market has split into two distinct segments: traditional palliative care and the high-growth "Disease-Modifying Drugs"...

0 Commentarii 0 Distribuiri 82 Views 0 previzualizare